-
Aroundtown (AT1 TH) +2%
- Aroundtown Boosts Full Year FFO I Per Share Forecast
- LVMH (MOH TH) +0.7%
-
Salmar (JEP TH) +0.6%
- Salmar Raised to Buy at Berenberg
-
ProSieben (PSM TH) +0.6%
- ProSieben at Non-Deal Roadshow Hosted By Kepler Cheuvreux Today
- Nemetschek (NEM TH) -0.3%
- Watch Design Software Stocks After Autodesk Forecast Misses
- Zalando (ZAL TH) -1.1%
-
Hannover Re (HNR1 TH) -1.5%
- Hannover Re Cut to Equal-Weight at Morgan Stanley
-
Knorr-Bremse (KBX TH) -2.9%
- Knorr-Bremse Comfirms FY Forecast After 9-Month Ebitda Increase
- Lufthansa (LHA TH) +0.6%
- Aroundtown (AT1 TH) +3%
- Aroundtown Boosts Full Year FFO I Per Share Forecast
- 1&1 Drillisch (DRI TH) +0.7%
- ProSieben (PSM TH) +0.7%
- Hannover Re (HNR1 TH) -1.5%
- Hannover Re Cut to Equal-Weight at Morgan Stanley
- Knorr-Bremse (KBX TH) -2.8%
- Knorr-Bremse Confirms FY Forecast After 9-Month Ebitda Increase
- TLG Immobilien (TLG TH) +2%
- Steinhoff (SNH TH) +1.7%
- DIC Asset (DIC TH) +1.4%
- Kloeckner (KCO TH) +1.3%
- Deutsche Euroshop (DEQ TH) -0.5%
- Deutsche Euroshop Cut to Reduce at HSBC; PT 24 euros
earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: BOX +2.8%, KEYS +1.9%, HPQ +1.5%, VMW +1.1%, VEEV +1%
Companies trading higher in after hours in reaction to news: MOV +1.2% (light volume; after closing lower by 20%)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CENT -11.7% (lightly traded), GES -4.6%, ADSK -1%
Companies trading lower in after hours in reaction to news: ARAV -13.8% (commenced public offering of common stock); MNK -2%, TEVA -0.6% (continued pressure following reports of federal opioid probe); DLTR -0.5% (ongoing weakness following earnings)
Gapping downGapping down
In reaction to disappointing earnings/guidance:
- MOV -20.6%, DLTR -8.4%, PANW -8.3% (also announced intention to acquire Aporeto for $150 mln in cash), CAL -6.7%, HPE -4.9%, BECN -3.4% (also announced upcoming departure of CFO Joseph Nowicki), A -3.4%, BITA -3.1%, TITN -2.9%
Other news:
- XFOR -9.4% (commenced public offering of common shares and Class B warrants)
- HBI -3% (announced departure of CFO Barry Hytinen)
- CLVS -2.8% (after closing Monday's session up by circa +19%)
- FTS -1% (launched C$1.1 bln of share offerings)
- ACAD -0.5% (announced top-line results from ADVANCE trial of pimavanserin)
Analyst comments:
- TAP -0.6% (downgraded to Market Perform from Outperform at BMO Capital Markets)
Gapping up
In reaction to strong earnings/guidance:
- NTNX +20.7%, DKS +12.9%, BBY +4.2%, DY +3.8%, AMBA +3.7%, CRH +2%, BURL +1.8%, PVH +1.4%, ARWR +1%, MOMO +0.9%, AMWD +0.9%, ANF +0.6%
Other news:
- CCXI +336.7% (co and Vifor Fresenius Medical announced "positive" top-line data from Phase III ADVOCATE trial of avacopan)
- KIN +19.9% (received FDA approval of Zimeta for control of equine pyrexia)
- SAFE +6.7% (appointed to join the S&P SmallCap 600)
- ARDX +5.8% (expands partnership with Kyowa Kirin with new agreements; receives $20 mln equity investment)
- EVFM +4.3% (resubmits New Drug Application to FDA for Amphora)
- GNFT +3.1% (announces that the Data Safety Monitoring Board issued positive recommendation for the continuation, without any modifications, of the RESOLVE-IT Phase 3 trial evaluating elafibranor in NASH)
- BCRX +1.5% (continued strength on light volume)
- CBAY +1.5% (after closing Monday's session down by 76%)
- AIG +1.2% (to sell majority interest in Fortitude Re for approx. $1.8 bln)
Analyst comments:
- CMG +1.7% (upgraded to Outperform from Market Perform at Cowen)
- DOC +1.3% (upgraded to Buy from Hold at Stifel)
- CERN +1.3% (initiated with a Buy at UBS)
- DIS +1.2% (initiated with an Overweight at Consumer Edge Research